Detalles de la búsqueda
1.
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Lancet Oncol
; 25(3): 376-387, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309282
2.
Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.
Biol Blood Marrow Transplant
; 25(8): e260-e267, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30926447
3.
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.
Biol Blood Marrow Transplant
; 25(11): 2160-2166, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279752
4.
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Biol Blood Marrow Transplant
; 25(5): 955-964, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30605731
5.
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.
Blood
; 128(8): 1050-8, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297790
6.
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Blood
; 123(23): 3655-63, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24735965
7.
Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.
Biol Blood Marrow Transplant
; 21(1): 142-50, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445638
8.
Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
Biol Blood Marrow Transplant
; 21(12): 2052-2060, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26271194
9.
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.
Br J Haematol
; 168(3): 405-12, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25272241
10.
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood
; 121(1): 197-206, 2013 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109243
11.
Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.
Biol Blood Marrow Transplant
; 20(5): 617-21, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508838
12.
Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services.
Transfusion
; 54(6): 1501-7, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24383419
13.
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update.
J Clin Oncol
; 42(13): 1472-1476, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427923
14.
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.
Front Immunol
; 12: 700045, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34539628
15.
Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
Biol Blood Marrow Transplant
; 16(1 Suppl): S8-S11, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19892026
16.
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.
Biol Blood Marrow Transplant
; 16(10): 1442-50, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20412867
17.
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 15(8): 903-9, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19589479
18.
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.
Clin Cancer Res
; 25(18): 5458-5465, 2019 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068369
19.
National marrow donor program session: donor issues.
Biol Blood Marrow Transplant
; 19(1 Suppl): S15-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23085601
20.
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biol Blood Marrow Transplant
; 14(8): 904-12, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18640574